ASTHMA AND OTORHINOLARYNGOLOGIC DISORDERS

Year 2003, Volume: 16 Issue: 4, 261 - 265, 03.12.2016

Müzeyyen Doğan Emel Eryüksel Tekin Bağlam Turgay Çelikel

Abstract

Objective: Upper respiratory disorders such as allergic rhinitis and rhinosinusitis are different facets of a larger systemic inflammatory syndrome involving both the upper and lower airways. Effective treatment of sinonasal disease, which is one of the factors that exacerbate asthma, may also improve and stabilize the asthmatic condition. Patients with persistent asthma should be searched for otorhinolaryngologic disorders. The aim of this study was to determine whether there is a an association between asthma and otolaryngologic disorders.
Methods: Forty-two asthmatic patients and 42 controls were examined for otorhinolaryngologic disorders by the same physician. Data were compared in groups by using Fisher’s Exact Test.
Results: Eighty-nine percent of the asthmatic patients were shown to have associated otorhinolaryngologic disorders which is significantly higher than in the controls (42%),(p<0,0001).
Conclusion: Upper respiratory disorder is a very common comorbidity of asthma and common mechanisms exist. The nasal and sinus inflammation in asthmatics seems to be related
specifically to asthma and is not a feature of all bronchial diseases. The presence of upper respiratory disorders should always be investigated in adults with asthma. Treatment of nasal conditions confers significant protection against asthma exacerbations.
Key Words: Asthma, Allergy, Polyps, Vocal cord dysfunction, Posterior laryngitis, Candidiasis.

References

• Canonica GW. Introduction to nasal and pulmonary allergy cascade. Allergy 2002;57 Suppl 75:8-12.
• American Thoracic Society.Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma.Am Rev Respir Dis 1987; 136:225- 234.
• Glovsky MM. Upper airways involvement in bronchia! asthma. Curr Opin Pulm Med 1998;4:54-58.
• rio authors listed. Overview of allergic
• diseases: Diagnosis, management, and
• barriers to care. The Allergy Report; Vol. I. Milwaukee, Wl: American Academy of Allergy, Asthma Sr Immunology; 2000.
• A s thm a a n d o to rh in o la r y n g o lo g ic d is o rd e rs
• Montne'mery P, Hi hie n U, Lo" fdahl CG, et al. The association between asthma, chronic bronchitis/emphysema and rhinitis, bur Respir J 2001 ; 18 Suppi:33:201s.
• Casale TB. Immunobiology of asthma and
• rhinitis: pathogenic factors and therapeutic options. In: American Thoracic Society
• Workshop Summary, Montreal, Quebec, Canada, 1997. Hew York: American Lung Association, 1999.
• Spector 5, Lee H, McHutt B, et al. Effect of terfenadine in asthmatic patients. Ann Allergy 1992;69:212-216.
• Bousquet J, Emonot A, Germouty J,et at. Double-blind multicentre study of cetirizine in grass-polleninduced asthma. Ann Allergy 1990;10:504-508.
• Spector SL, Hicodemus CE, Corren J, et al Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-tomoderate asthma. J Allergy Clin Immunol 1995;96:1 74- 181.
• flaruna S, Hakanishi PI, Otori H, Moriyama li. Histopathological features of nasal polyps with asthma association: an
• immunohistochemical study. Am J Rhinol 2004;18:165-172.
• Batra PS, Kern RC, Tripathi A, et al. Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma. Laryngoscope 2003; 113:1 703-1 706.
• Ragab A, Clement P, Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol 2004;18:15-21.
• Perkner JJ, Eennelly KP, Balkissoon R, et al. Irritant associated vocal cord dysfunction. J Occup Environ Med 1998;2:136-144.
• Altman KW, Simpson CB, Amin M, et al. Cough and paradoxical vocal fold motion. Otolaryngol Head Heck Surg 2002; 127:501- 511.
• Fukushima C, Matsuse H, Tomari S, et al. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003;90:646-651.
• Lawrence M, Wolfe J, Webb DR, et al. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity. Am J Respir Crit